ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma

Figure 5

(a) Summary of estimated compositions of 22 immune cell subtypes from the CIBERSORT algorithm in HCC patients. (b) Comparison of 22 immune cell subtypes between low- and high-risk samples. (c) The correlation between ARID1A and infiltrating immune cells in patients with HCC.

(a)

(b)

(c)